Albumin to globulin ratio (AGR) in systemic lupus erythematosus: correlation with disease activity

被引:1
作者
Liu, Meng [1 ]
Li, Xingjian [1 ,2 ]
Huang, Yukai [1 ]
Huang, Zhengping [1 ]
Huang, Qidang [1 ]
机构
[1] Guangdong Second Prov Gen Hosp, Dept Rheumatol & Immunol, 466 Xingangzhong Rd, Guangzhou 510317, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China
关键词
Systemic lupus erythematosus; albumin to globulin ratio; disease activity; complement C4; independent risk factors; inflammatory biomarker; CORTICOSTEROID-BINDING GLOBULIN; TO-LYMPHOCYTE RATIO; PRETREATMENT ALBUMIN; NEUTROPHIL; GUIDELINES; PLATELET; MARKER; PLR; NLR;
D O I
10.1177/03000605241244761
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective To investigate the role of albumin-to-globulin ratio (AGR) in systemic lupus erythematosus (SLE) and its relationship with disease activity. Methods This retrospective study consecutively selected patients with SLE and healthy controls. Patients were divided into three groups according to the SLE Disease Activity Index 2000 (SLEDAI-2K): group 1 (mild disease activity, SLEDAI-2K <= 6), group 2 (moderate disease activity, SLEDAI-2K 7-12) and group 3 (severe disease activity, SLEDAI-2K > 12). Predictors of SLE disease activity were analysed by ordinal logistical regression. Results A total of 101 Chinese patients with SLE and 75 healthy Chinese controls were included. Patients with SLE had lower AGR values than healthy individuals, and group 3 patients with SLE displayed lower AGR values than those in group 1, but similar values to group 2. AGR was inversely correlated with SLEDAI-2K (r = -0.543). Ordinal logistic regression analysis showed that lower AGR (beta = -1.319) and lower complement C4 (beta = -1.073) were independent risk factors for SLE disease activity. Conclusions AGR was decreased in patients with SLE and may be utilized as a useful inflammatory biomarker for monitoring SLE disease activity.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus
    Shimada, Yuki
    Asanuma, Yu Funakubo
    Yokota, Kazuhiro
    Yoshida, Yoshihiro
    Kajiyama, Hiroshi
    Sato, Kojiro
    Akiyama, Yuji
    Mimura, Toshihide
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 78 - 85
  • [32] Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices
    Griffiths, B
    Mosca, M
    Gordon, C
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (05): : 685 - 708
  • [33] FAR in systemic lupus erythematosus: a potential biomarker of disease activity and lupus nephritis
    Xu, Jili
    Zhang, Hongmei
    Che, Nan
    Wang, Hengjin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4779 - 4785
  • [34] Ovarian function and disease activity in patients with systemic lupus erythematosus
    Shabanova, S. S.
    Ananieva, L. P.
    Alekberova, Z. S.
    Guzov, I. I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (03) : 436 - 441
  • [35] Validity of retrospective disease activity assessment in systemic lupus erythematosus
    ArceSalinas, A
    Cardiel, MH
    Guzman, J
    AlcocerVarela, J
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (05) : 846 - 849
  • [36] Association of urine autoantibodies with disease activity in systemic lupus erythematosus
    Zhang, Yuxian
    Qu, Xiaoxia
    Wang, Lishui
    Song, Lijun
    FRONTIERS IN MEDICINE, 2024, 11
  • [37] Accurately describing changes in disease activity in systemic lupus erythematosus
    Gladman, DD
    Urowitz, MB
    Kagal, A
    Hallett, D
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (02) : 377 - 379
  • [38] Assessment Of disease activity in Systemic Lupus Erythematosus: Lights and shadows
    Ceccarelli, Fulvia
    Perricone, Carlo
    Massaro, Laura
    Cipriano, Enrica
    Alessandri, Cristiano
    Spinelli, Francesca Romana
    Valesini, Guido
    Conti, Fabrizio
    AUTOIMMUNITY REVIEWS, 2015, 14 (07) : 601 - 608
  • [39] Evaluation of red blood cell distribution width-platelet ratio as a predictor of adverse pregnancy outcomes and disease severity in systemic lupus erythematosus
    Wang, Jingjing
    He, Xiaodan
    Jiang, Dongbin
    Wang, Zhenbo
    Xu, Dalin
    Chen, Jianqiang
    Gao, Guanmin
    Liu, Xiaokang
    CLINICAL RHEUMATOLOGY, 2022, 41 (10) : 2987 - 2993
  • [40] FAR in systemic lupus erythematosus: a potential biomarker of disease activity and lupus nephritis
    Jili Xu
    Hongmei Zhang
    Nan Che
    Hengjin Wang
    Clinical and Experimental Medicine, 2023, 23 : 4779 - 4785